Table 2 Overall Summary of Adverse Events in Retreatment Group A and Nonretreatment Group B
Nonretreatment Group B | Retreatment Group A | |||
|---|---|---|---|---|
(N = 106) | (N = 125) | |||
Events | Patients (%) | Events | Patients (%) | |
AEs | 187 | 73 (68.9) | 233 | 84 (67.2) |
AEs occurring in ≥5 % of patients | ||||
Joint swelling | 33 | 27 (25.5) | 49 | 37 (29.6) |
Joint effusion | 29 | 24 (22.6) | 35 | 30 (24.0) |
Arthralgia | 22 | 17 (16.0) | 24 | 19 (15.2) |
Upper respiratory tract infection | 3 | 3 (2.8) | 13 | 13 (10.4) |
Related AEs | 48 | 27 (25.5) | 59 | 31 (24.8) |
Related AEs occurring in ≥5 % of patients | ||||
Joint swelling | 15 | 14 (13.2) | 22 | 15 (12.0) |
Joint effusion | 13 | 12 (11.3) | 14 | 12 (9.6) |
Arthralgia | 9 | 7 (6.6) | 13 | 10 (8.0) |